IgA nephropathy: Analysis of the natural history, important factors in the progression of renal disease, and a review of the literature

Medicine (United States)

Volumn 73, Issue 2, 1994, Pages 79-102

  Ibels, Lloyd S ^a   Györy, Akos Z ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A;

ADULT; AGED; ARTICLE; CHILD; CLINICAL FEATURE; DISEASE COURSE; ELECTRON MICROSCOPY; FEMALE; FOLLOW UP; HUMAN; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN DEPOSITION; KIDNEY BIOPSY; KIDNEY FUNCTION; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SURVIVAL;

GLOMERULONEPHRITIS, IGA; HUMAN; KIDNEY; PROGNOSIS;

EID: 0028296988     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/00005792-199403000-00002     Document Type: Article

References (266)

1. Abe S. Pregnancy in IgA nephropathy. Kidney Int 40: 1098-1102, 1991.
2. Abe S, Amagasaki Y, Iyori S, Koniahi K, Kato E, Sakaguchi H. Significance of tubulointerstitial lesions in biopsy specimens of glomerulonephritic patients. Am J Nephrol 9: 30-37, 1989.
3. Abe S, Amagasaki Y, Konishi K, Kato E, Sakaguchi H, Iyori S. The influence of antecedent renal diaeaae on pregnancy. Am J Obstet Gynecol 153:508-14, 1985.
4. Abe T, Kida H, Yoshimura M, Yokoyama H, Koehino Y, Tomosugi N, Hattori N. Participation of extracapillary lesions (ECL) in progression of IgA nephropathy. Clin Nephrol 25:37-41, 1986.
5. Abuelo JG, Esparza AR, Matareae RA, Endreny RG, Carvalho JS, Allegro SR. Crescentic IgA nephropathy. Medicine (Baltimore) 63: 396-406, 1984.
6. Alamartine E, Sabatier JC, Berthoux FC. Comparison of pathological lesions on repeated renal biopsies in 73 patients with primary IgA glomerulonephritis: Value of quantitative scoring and approach to final prognosis. Clin Nephrol 34:46-51, 1990.
7. Alamartine E, Sabatier JC, Guerin C, Berliet JM, Berthoux F. Prognostic factors in mesangial IgA glomerulonephritis: An extensive study with univariate and multivariate analysis. Am J Kidney Dis 18:12-19, 1991.
8. Alexander F, Barabas AZ, Jack RGJ. IgA nephropathy. Hum Pathol 8:173-185, 1977.
9. Alexopouloe E, Seron D, Hartley RB, Nolasco F, Cameron JS. The role of interstitial infiltrates in IgA nephropathy: A study with monoclonal antibodies. Nephrol Dial Transplant 4:187-195, 1989.
10. Andreoli SP, Bergstein JM. Treatment of severe IgA nephropathy in children. Pediatr Nephrol 3: 248-253, 1989.
11. Arnais-Villena A, Gonzalo A, Mampaao F, Temel JL, Ortunno J. HLA and IgA nephropathy in Spanish population. Tissue Antigens 17: 549-550, 1981.
12. Autuly V, Laruelle E, Benziane A, Ang KS, Cam G, Ramée MP, Simon P. Increased genetic risk of hypertension in immunoglobulin A nephropathy but not in membranous nephropathy. J Hypertens [Suppl] 9: S220-S221, 1991.
13. Ballardie FW, O'Donoghue DJ, Feehally J. Increasing frequency of adult IgA nephropathy in the UK? Lancet ii: 1205, 1987.
14. Belovezhdov N, Robeva R. Clinical and therapeutic studies in mesangial immunoglobulin A glomerulonephritis. Int Urol Nephrol 19: 341-345, 1987.
15. Bennett WM, Kincaid-Smith P. Macroscopic hematuria in mesangial IgA nephropathy: Correlation with glomerular crescents and renal dysfunction. Kidney lot 23: 393-400, 1983.
16. Bennett WM, Walker RG, Kincaid-Smith P. Renal cortical interstitial volume in mesangial IgA nephropathy: Dissociation from creatinine clearance in serially biopsied patients. Lab Invest 47: 330-335, 1982.
17. Bennett WM, Walker RG, Kincaid-Smith P. Treatment of IgA nephropathy with eicosapentanoic acid (EPA): A two-year prospective trial. Clin Nephrol 31:128-131, 1989.
18. Berger J. IgA glomerular deposits in renal disease. Transplant Proc 1: 939-944, 1969.
19. Berger J. Recurrence of IgA nephropathy in renal allografts. Am J Kidney Dis 12: 371-372, 1988.
20. Berger J, Hinglais N. Les dépôts intercapillaires d'lgA-IgG. J Urol Nephrol 74:694-695, 1968.
21. Berger J, Yaneva H, Nabarra B, Barbanel C. Recurrence of mesangial deposition of IgA after renal transplantation. Kidney Int 7:232-241, 1975.
22. Berthoux FC, Gagne A, Sabatier JC, Ducret F, Le Petit JC, Marcellin M, Mercier B, Brizard CP. HLA-Bw35 and mesangial IgA glomerulonephritis. N Engl J Med 298:1034-1035, 1978.
23. Berthoux FC, Genin C, Gagne A, Le Petit JC, Sabatier JC. HLA-Bw35 antigen and mesangial IgA glomerulonephritis: A poor prognosis marker? Proc Eur Dial Transplant Assoc 16: 551-555, 1979.
24. Beukhof JR, Kardaun O, Ockhuizen T, van der Hem GK. Kidney survival in IgA nephropathy: Multiple regression analysis of genetically differing subpopulations: Is IgA nephropathy a real dis esse entity? Semin Nephrol 7:367-369, 1987.
25. Beukhof JR, Kardaun O, Schaafama W, Poortema K, Donker AJ, Hoedemaeker PJ, van der Hem GK. Toward individual prognosis of IgA nephropathy. Kidney Int 29:549-556, 1986.
26. Beukhof JR, Ockhuiaen Th, Fleuren GJ, Haas M, Donga J, Donker AJM, Hoedemaeker PhJ, van der Hem GK. Relation between proteinuria and morphology in IgA nephropathy. Contrib Nephrol 40: 228-235, 1984.
27. Bignon JD, Housain A, Soulillou JP, Denis J, Guimbretiere J, Guenel J. HLA antigens and Berger's disease. Tissue Antigens 16:108-111, 1960.
28. Boobes Y, Baz M, Durand C, Jaber K, Goldstein P, Berland Y. Early start of intensive therapy in malignant form of IgA nephropathy. Nephron 54: 351-353, 1990.
29. Boyce NW, Hokkworth SR, Thomson NM, Atkina RC. Clinicopathoiogical associations in mesangial IgA nephropathy. Am J Nephrol 6: 246-252, 1966.
30. Bógenschutz O, Bohle A, Batz C, Wehrmann M, Preaaler H, Kendziorra H, Gertner HV. IgA nephritis: On the importance of morphological and clinical parameters in the long-term prognosis of 239 patients. Am J Nephrol 10:137-147, 1990.
31. Brattle R, Peters DK, Batchelor JR. Mesangial IgA glomerulonephritis and HLA antigens. N Engl J Med 299: 200, 1978.
32. Cameron JS. Glomerulonephritis in renal transplants. Transplantation 34: 237-245, 1982.
33. Cameron JS. The long-term outcome of glomerular diseases. In: Schrier RW, Gottachalk CW, eds. Diseases of the kidney. 4th ed. Boston: Little, Brown, pp. 2127-2189, 1988.
34. Camussi G, Stratta P, Segoloni G, Caramello E, Ragni R, Vercellone A. Predominant mesangial IgA deposits in glomerulonephritis: A clinical, histopathologic and immunohistochemical comparative study. Kidney Int 9: 526, 1976.
35. Chan SH, Ku G, Sinniah R. HLA and Chinese IgA mesangial glomerulonephritis. Tissue Antigens 17: 351-352, 1981.
36. Cheng IKP, Chan PCK, Chan MK. The effect of fish-oil dietary supplement on the progression of mesangial IgA glomerulonephritis. Nephrol Dial Transplant 5: 241-246, 1990.
37. Cheong I, Kong N, Segasothy M, Moras Z, Menon P, Suleiman AB. IgA nephropathy in Malaysia. Southeast Asian J Trap Med Public Health 22:120-122, 1991.
38. Chida Y, Tomura S, Takeuchi J. Renal survival rate of IgA nephropathy. Nephron 40:189-194, 1985.
39. Clarkson AR, Seymour AE, Thompson AJ, Haynes WDG, Chan Y-L, Jackson B. IgA nephropathy: A syndrome of uniform morphology, diverse clinical features and uncertain prognosis. Clin Nephrol 8: 459-471, 1977.
40. Clarkson AR, Seymour AE, Woodroffe AJ, McKenzie PE, Chan Y-L, Wootton AM. Controlled trial of phenytoin therapy in IgA nephropathy. Clin Nephrol 13: 215-218, 1980.
41. Clarkson AR, Woodroffe AJ, Aarons I. IgA nephropathy in patients followed-up for at least ten years. Semin Nephrol 7: 377-378, 1987.
42. Clarkson AR, Woodroffe AJ, Bannister KM, Lomax-Smith JD, Aarons I. The syndrome of IgA nephropathy. Clin Nephrol 21: 7-14, 1984.
43. Coppo R, Roccatello D, Amore A, Quattrocchio G, Molino A, Gianoglio B, Amoroso A, Bajardi P, Piccoli G. Effects of a gluten-free diet in primary IgA nephropathy. Clin Nephrol 33: 72-86, 1990.
44. Cosio FG, Lam S, Folami AO, Conley ME, Michael AF. Immune regulation of immunoglobulin production in IgA-nephropathy. Clin Immunol Immunopathol 23: 430-436, 1982.
45. Costa RS, Droz D, Nöel LH. Long-standing spontaneous clinical remission and glomerular improvement in primary IgA nephropathy (Berger's disease). Am J Nephrol 7: 440-444, 1987.
46. Cox DR. Regression models and life tables. J R Stat Soc (B) 34: 187-202, 1972.
47. Croker BP, Dawson DV, Sanfilippo F. IgA nephropathy: Correlation of clinical and histologic features. Lab Invest 48:19-24, 1983.
48. D'Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 64: 709-727, 1987.
49. D'Amico G. Idiopathic IgA mesangial nephropathy. Nephron 41: 1-13, 1985.
50. D'Amico G. Influence of clinical and histological features on actuarial renal survival in adult patients with idiopathic IgA nephropathy, membranous nephropathy, and membranoproliferative glomerulonephritis: Survey of the recent literature. Am J Kidney Dis 20: 315-323, 1992.
51. D'Amico G. The natural history of IgA disease. Contrib Nephrol 70: 116-120, 1989.
52. D'Amico G, Barbiano di Belgiojoso G, Imbasciati E, Fogazzi G, Radaelli L, Ferrario F, Fellin G, Ponticelli C, Minetti L. Idiopathic IgA mesangial nephropathy: Natural history. Contrib Nephrol 40: 208-213, 1984.
53. D'Amico G, Colasanti G, Barbiano di Belgioioso G, Fellin G, Ragni A, Egidi F, Radaelli L, Fogazzi G, Ponticelli C, Minetti L. Longterm follow-up of IgA mesangial nephropathy: Clinico-histological study in 374 patients. Semin Nephrol 7:355-358, 1987.
54. D'Amico G, Ferrario F, Colasanti G, Ragni A, Bestetti Bosisio M. IgA-mesangial nephropathy (Berger's disease) with rapid decline in renal function. Clin Nephrol 16: 251-257, 1981.
55. D'Amico G, Imbasciati E, Barbiano di Belgioioso G, Bertoli S, Fogazzi G, Ferrario F, Fellin G, Ragni A, Colasanti G, Minetti L, Ponticelli C. Idiopathic IgA mesangial nephropathy: Clinical and histological study of 374 patients. Medicine (Baltimore) 64: 49-60, 1985.
56. D'Amico G, Minetti L, Ponticelli C, Fellin G, Ferrario F, Barbiano di Belgioioso G, Imbasciati E, Ragni A, Bertoli S, Fogazzi G, Duca G. Prognostic indicators in idiopathic IgA mesangial nephropathy. QJ Med 59: 363-378, 1986.
57. D'Amico G, Ragni A, Torpia R. Factors of progression in IgA mesangial nephropathy. Contrib Nephrol 75: 76-81, 1989.
58. D'Amico G, Vandemia F. Hypertension in IgA nephropathy. Contrib Nephrol 54:113-118, 1987.
59. Davies DR, Tighe JR, Jones NF, Brown GW. Recurrent haematuria and mesangial IgA deposition. J Clin Pathol 26: 672-677, 1973.
60. Davies DR, Tighe JR, Jones NF. Isolated glomerulonephritis with mesangial IgA deposition. Br Med J 4:103, 1975.
61. Degli Esposti E, Zucchelli P, Chiarini C, Santoro A, Sturani A, Zuccala A, Gagnoli L, Donini U, Mandreoli M, Pasquali S. Berger's nephropathy: Relationship between histological pattern, blood pressure and renin. Proc Eur Dial Transplant Assoc 19: 696-700, 1983.
62. Diaz-Tejeiro R, Maduell F, Diez J, Esparza N, Errasti P, Purroy A, Pardo J. Loss of renal graft due to recurrent IgA nephropathy with rapidly progressive course: An unusual clinical evolution. Nephron 54: 341-343, 1990.
63. Disney APS, ed. ANZDATA report 1992. Adelaide, South Australia: Australia and New Zealand Dialysis and Transplant Registry, 1992.
64. Doyle GD, O'Dwyer WF, Carmody M, Campbell E, Browne O. IgA nephropathy-an immunopathological study. Ir J Med Sci 145:292-303, 1976.
65. Droz D, Kramar A, Nawar T, Nöel LH. Primary IgA nephropathy: Prognostic factors. Contrib Nephrol 40: 202-207, 1984.
66. Droz D. Natural history of primary glomerulonephritis with mesangial deposits of IgA. Contrib Nephrol 2:150-157, 1976.
67. Egido J, Julian BA, Wyatt RJ. Genetic factors in primary IgA nephropathy. Nephrol Dial Transplant 2:134-142, 1987.
68. Egido J, Rivera F, Sancho J, Barat A, Hernando L. Phenytoin in IgA nephropathy: A long-term controlled trial. Nephron 38: 30-39, 1984.
69. Emancipator SN, Gallo GR, Lamm M. IgA nephropathy: Perspectives on pathogenesis and classification. Clin Nephrol 24: 161-179, 1985.
70. Fauchet R, Le Pogamp P, Genetet B, Chevet D, Guéguen M, Simon P, Ramée MP, Cartier F. HLA-DR4 antigen and IgA nephropathy. Tissue Antigens 16: 405-410, 1980.
71. Feehally J, Dyer PA, Davidson JA, Harris R, Mallick NP. Immunogenetics of IgA nephropathy: Experience in a UK centre. Dis Markers 2:493-500, 1984.
72. Feehally J, O'Donoghue DJ, Ballardie FW. Current nephrological practice in the investigation of haematuria: Relationship to incidence of IgA nephropathy. J R Coll Physicians Lond 23: 228-231, 1989.
73. Feiner HD, Cabili S, Baldwin DS, Schacht RG, Gallo GR. Intrarenal vascular sclerosis in IgA nephropathy. Clin Nephrol 18: 183-192, 1982.
74. Feiner HD, Galvin S, Neelakantappa K, Baldwin D, Gallo GR. Vessel sclerosis and progression in IgA nephropathy. Contrib Nephrol 40: 222-227, 1984.
75. Finlayson G, Alexander R, Juncos L, Schlein E, Teague P, Waldman R, Cade R. Immunoglobulin A glomerulonephritis: A clinicopathologic study. Lab Invest 32:140-148, 1975.
76. Francisco S, Wall BM, Cooke CR. Immunoglobulin A nephropathy in a renal allograft of a Black transplant recipient. Am J Nephrol 12:121-125, 1992.
77. Frasca GM, Vangelista A, Biagini G, Bonomini V. Immunological tubulointerstitial deposits in IgA nephropathy. Kidney Int 22:184191, 1982.
78. Fukushi K, Yamabe H, Ozawa K, Kubota H, Osawa H, Chiba N, Onodera K, Oike Y. Clinico-pathological evaluation of IgA nephropathy associated with nephrotic syndrome. Jpn J Nephrol 30: 247-251, 1988.
79. Gallo GR, Kataiuchi R, Neelakantappa K, Baldwin DS. Prognostic pathologic markers in IgA nephropathy. Am J Kidney Dis 12: 362-365, 1988.
80. Gärtner H-V, Hönlein F, Traub U, Bohle A. IgA-nephropathy (IgA-IgA-nephropathy/IgA-nephritis)-a disease entity? A comparative analysis of immunohistologic, histologic and clinical findings in 166 renal biopsies of 153 patients. Virchows Arch [A] 385:1-27, 1979.
81. Glassock RJ, Adler SG, Ward HJ, Cohen AH. Primary glomerular diseases. In: Brenner BM, Rector FC, eds. The kidney. 4th ed. Philadelphia: Saunders, pp. 1182-1279, 1991.
82. Grazi G, Cirami C, Panichi V, Bianchi AM, Parrini M, Baronti A, Cominotto R, Montagnani E, Palla R. Renal effects of enalapril in hypertensive patients with glomerulonephritis. Nephrol Dial Transplant 4: 396-398, 1989.
83. Habib R, Murcia I, Beaufils H, Niaudet P. Primary IgA nephropathies in children. Biomed Pharmacother 44:159-162, 1990.
84. Hall RP, Stachura I, Cason J, Whiteside TL, Lawley TJ. IgA-containing circulating immune complexes in patients with IgA nephropathy. Am J Med 74: 56-63, 1983.
85. Hara M, Endo Y, Nihei H, Hara S, Fukushima O, Mimura N. IgA nephropathy with subendothelial deposits. Virchows Arch [A] 386: 249-263, 1980.
86. Healy JK, Searle JW, Monnington PK. Exacerbations of IgA nephropathy with recurrent acute mastitis. Am J Kidney Dis 16: 166-167, 1990.
87. Hiki Y, Kobayashi Y, Ookubo M, Kashiwagi N. The role of HLA-DR4 in the longterm prognosis of IgA nephropathy. Nephron 54: 264-265, 1990.
88. Hiki Y, Kobayashi Y, Tateno S. Strong association of HLA-DR4 with benign IgA nephropathy. Nephron 32: 222-226, 1982.
89. Hogg RJ, Savino DA. Spontaneous remission of nephrotic syndrome in a patient with IgA nephropathy. Pediatr Nephrol 4: 36-38, 1990.
90. Hogg RJ, Silva FG. IgA nephropathy: Natural history and prognostic indices in children. Contrib Nephrol 40: 214-221, 1984.
91. Hood SA, Velosa JA, Holley KE, Donadio JV Jr. IgA-IgG nephropathy: Predictive indices of progressive disease. Clin Nephrol 16:5562, 1981.
92. Hotta O, Yoshizawa N, Oshima S, Takeuchi A, Kawamura O, Hondo S, Kubota T, Niwa H. Significance of renal hyaline arteriosclerosis and tubulo-interstitial change in IgA glomerulonephropathy and focal glomerular sclerosis. Nephron 47: 262-265, 1987.
93. Huang C-C, Hu S-A, Lin J-L, Wu J-H. HLA and Chinese IgA nephropathy in Taiwan. Tissue Antigens 33: 45-47, 1989.
94. Huissoon AP, Meehan S, Keogh JA. Reduction of proteinuria with captopril therapy in patients with focal segmental glomerulosclerosis and IgA nephropathy. Ir J Med Sci 160: 319-321, 1991.
95. Hyman LR, Wagnild JP, Beime GJ, Burkholder PM. Immunoglobulin-A distribution in glomerular disease: Analysis of immunofluorescence localization and pathogenetic significance. Kidney Int 3: 397-408, 1973.
96. Ibels LS. Atherosclerosis, nephrocalcinosis and progressive renal failure: Inevitable but potentially retardable complications of chronic renal disease. MD thesis, University of Sydney, Sydney, Australia, pp. 1204-1219, 1990.
97. Imbasciati E, Colasanti G, Barbiani di Belgioioso G, Banfi G, Durante A, Ragni A, Ponticelli C, Minetti L, D'Amico G. Long term follow up of IgA mesangial deposits glomerulonephritis. Proc Eur Dial Transplant Assoc 14: 472-477, 1977.
98. Jennette JC, Wall SD, Wilkman AS. Low incidence of IgA nephropathy in blacks. Kidney Int 28: 944-950, 1985.
99. Jennette JC. The immunohistology of IgA nephropathy. Am J Kidney Dis 12: 348-352, 1988.
100. Jindal KK, Trillo A, Bishop G, Hirsch D, Cohen A. Crescentic IgA nephropathy as a manifestation of human immune deficiency virus infection. Am J Nephrol 11:147-150, 1991.
101. Johnston PA, Brown JS, Braumholtz, Davison AM. Clinico-pathological correlations and long-term follow-up of 253 United Kingdom patienta with IgA nephropathy: A report from the MRC Glomerulonephritis Registry. Q J Med 84: 619-627, 1992.
102. Joshua H, Sharon Z, Gutglas E, Rosenfeld J, Ben-Baasat M. IgA-IgG nephropathy: A clinicopathologic entity with slow evolution and favorable prognosis. Am J Clin Pathol 67: 289-295, 1977.
103. Julian BA. First National Symposium on IgA Nephropathy. Am J Kidney Dis 12: 337, 1988.
104. Julian BA, Quiggins PA, Thompson JS, Woodford SY, Gleason K, Wyatt RJ. Familial IgA nephropathy: Evidence of an inherited mechanism of disease. N Engl J Med 312: 202-208, 1985.
105. Julian BA, Waldo B, Rifai A, Meatecky J. IgA nephropathy, the most common glomerulonephritis worldwide: A neglected disease in the United States? Am J Med 84:129-132, 1988.
106. Julian BA, Wyatt RJ, McMorrow RG, Galla JH. Serum complement proteins in IgA nephropathy. Clin Nephrol 20: 251-258, 1983.
107. Jungera P, Forget D, Houillier P, Henry-Amar M, Grunfeld JP. Pregnancy in IgA nephropathy, reflux nephropathy, and focal glomerular sclerosis. Am J Kidney Dis 9: 334-338, 1987.
108. Jungera P, Houillier P, Forget D, Henry-Amar M. Specific controversies concerning the natural history of renal disease in pregnancy. Am J Kidney Dia 17:116-122, 1991.
109. Kaplan EL, Meier P. Nonparametric estimation for incomplete observations, J Am Stat Assoc 53:457-481, 1958.
110. Kaahiwabara H, Shishido H, Tomura S, Tuchida H, Miyajima T. Strong association between IgA nephropathy and HLA-DR4 antigen. Kidney Int 22:377-382, 1982.
111. Kashiwabara H, Shishido H, Yokoyama T, Miyajima T. HLA in IgA nephropathy. Tissue Antigens 16: 411-412, 1980.
112. Katafuchi R, Takebayashi S, Taguchi T, Harad T. Structuralfunctional correlations in serial biopsies from patients with glomerulonephritis. Clin Nephrol 28:169-173, 1987.
113. Katafuchi R, Vamvakas E, Neelakantappa K, Baldwin DS, Gallo GR. Microvascular disease and the progression of IgA nephropathy. Am J Kidney Dis 15: 72-79, 1990.
114. Katz A, Underdown BJ, Mints JO, Lepow IH. Glomerulonephritis with mesangial deposits of IgA unassociated with systemic disease. Can Med Assoc J 114: 209-215, 1976.
115. Katz A, Walker JF, Landy PJ. IgA nephritis with nephrotic range proteinuria. Clin Nephrol 20: 67-71, 1983.
116. Kesson AM, Talbott JM, Györy AZ. Microscopic examination of urine. Lancet i: 809-812, 1978.
117. Kincaid-Smith P, Bennett WM, Dowling JP, Ryan GB. Acute renal failure and tubular necrosis associated with hematuria due to glomerulonephritis. Clin Nephrol 19: 206-210, 1983.
118. Kincaid-Smith P, Fairley KF. Renal disease in pregnancy. Three controversial areas: Mesangial IgA nephropathy, focal glomerular sclerosis (focal and segmental hyalinosis and sclerosis), and reflux nephropathy. Am J Kidney Dis 9: 328-333, 1987.
119. Kincaid-Smith P, Nicholls K. Mesangial IgA nephropathy. Am J Kidney Dis 3: 90-102, 1983.
120. Kincaid-Smith PS, Whitworth JA, Fairley KF. Mesangial IgA nephropathy in pregnancy. Clin Exp Hypertens 2:821-838, 1980.
121. Kincaid-Smith PS. Mesangial IgA nephropathy. Br Med J 290: 96-97, 1985.
122. Kitajima T, Murakami M, Sakai O. Clinicopathological features in the Japanese patients with IgA nephropathy. Jpn J Med 22: 219222, 1983.
123. Kobayashi Y, Fujii K, Hiki Y, Tateno S. Steroid therapy in IgA nephropathy: A prospective pilot study in moderate proteinuric cases. Q J Med 61:935-943, 1986.
124. Kobayashi Y, Hiki Y, Fujii K, Kurokawa A, Kamiyana M, Tateno S. IgA nephropathy: Heterogeneous clinical pictures and steroid therapy in progressive cases. Semin Nephrol 7: 382-385, 1987.
125. Kobayashi Y, Hiki Y, Fujii K, Kurokawa A, Tateno S. Moderately proteinuric IgA nephropathy: Prognostic prediction of individual clinical courses and steroid therapy in progressive cases. Nephron 53: 250-256, 1989.
126. Kobayashi Y, Tateno S, Hiki Y, Shigematsu H. IgA nephropathy: Prognostic significance of proteinuria and histological alterations. Nephron 34:146-153, 1983.
127. Komori K, Nose Y, Inouye H, Tsuji K, Nomoto Y, Sakai H. Study on HLA system in IgA nephropathy. Tissue Antigens 14: 32-36, 1979.
128. Koselj M, Rott T, Vizjak A, Kveder R. IgA nephropathy as a donortransmitted disease in renal transplant recipients. Transplant Proc 23: 2643-2646, 1991.
129. Kupor LR, Mullins JD, McPhaul JJ. Immunopathological findings in idiopathic renal hematuria. Arch Intern Med 135: 1204-1211, 1975.
130. Kusumoto Y, Takebayashi S, Taguchi T, Harada T, Naito S. Longterm prognosis and prognostic indices of IgA nephropathy in juvenile and in adult Japanese. Clin Nephrol 28:118-124, 1987.
131. Lagrue G, Intrator L, Hirbec G, Foumel M. Modifications des IgA seriques dans les glomérulonéphrites mésangiales dépôt d'lgA. Nouv Presse Med 3:827, 1974.
132. Lai KN, Ho CP, Chan KW, Yan KW, Lai FM, Vallance-Owen J. Nephrotic range proteinuria-a good predictive index of disease in IgA nephropathy? Q J Med 57: 677-688, 1985.
133. Lai KN, Lai FM, Ho CP, Chan KW. Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: A long-term controlled trial. Clin Nephrol 26:174-180, 1986.
134. Laurent J, Belghiti D, Bruneau C, Lagrue G. Diclofenac, a nonsteroidal anti-inflammatory drug, decreases proteinuria in some glomerular diseases: A controlled study. Am J Nephrol 7: 198-202, 1987.
135. Lawler W, Williams G, Tarpey P, Acheson EJ, Mallick NP. IgA localisation in glomerular diseases. J Clin Pathol 30:914-924, 1977.
136. Lee GSL, Woo KT, Tim CH. Controlled trial of dipyridamole and low-dose warfarin in patients with IgA nephritis with renal impairment. Clin Nephrol 31:276, 1989.
137. Lee HS, Choi Y, Lee JS, Yu BH, Koh HI. Uhrastructural changes in IgA nephropathy in relation to histologic and clinical data. Kidney Int 35:880-886, 1989.
138. Lee HS, Koh HI, Lee HB, Park HC. IgA nephropathy in Korea: A morphological and clinical study. Clin Nephrol 27:131-140, 1987.
139. Lee S-M K, Rao VM, Franklin WA, Schifier MS, Aronson AJ, Spargo BH, Katz AI. IgA nephropathy: Morphologic predictors of progressive renal disease. Hum Pathol 13: 314-322, 1982.
140. Levy M, Beaufils H, Gubler MC, Habib R. Idiopathic recurrent macroscopic hematuria and mesangial IgA-IgG deposits in children. Clin Nephrol 1: 63-68, 1973.
141. Levy M, Gonzalez-Burchard G, Broyer M, Dommergues J-P, Foulard M, Sorez J-P, Habib R. Berger's disease in children: Natural history and outcome. Medicine (Baltimore) 64:157-180, 1985.
142. Li PK-T, Burns AP, So AKL, Pusey CD, Feehally J, Rees AJ. The DQw7 allele at the HLA-DQB locus is associated with susceptibility to IgA nephropathy in Caucasians. Kidney Int 39: 961-965, 1991.
143. Lim EC, Terasaki PI. Outcome of renal transplantation in different primary diseases. Clin Transpl: 293-303, 1991.
144. Linné T, Aperia A, Broberger O, Bergstrand A, Bohman S-O, Rekola S. Course of renal function in IgA glomerulonephritis in children and adolescents. Acta Paediatr Stand 71: 735-743, 1982.
145. Lomax-Smith JD, Woodroffe AJ, Clarkson AR, Seymour AE. IgA nephropathy-enaccumulated experience and current concepts. Pathology 17: 219-244, 1985.
146. Lowance DC, Mullins JD, McPhaul JJ. Immunoglobulin A (IgA) associated glomerulonephritis. Kidney Int 3:167-176, 1973.
147. Lupo A, Rugiu C, Cagnoli L, Zucchelli P, Maschi G. Acute changes in renal function in IgA nephropathy. Semin Nephrol 7: 359-362, 1987.
148. Magil AB, Ballon HS. IgA nephropathy. Evaluation of prognostic factors in patients with moderate disease. Nephron 47: 246-252, 1987.
149. Makker SP, Kher KK. IgA nephropathy in children. Semin Nephrol 9:112-115, 1989.
150. Marcén R, Pascual J, Felipe C, Mampaso F, Gonzalo A, Orofino L, Ortuño J. Recurrence of IgA nephropathy with nephrotic syndrome after kidney transplantation. Nephron 59: 486-489, 1991.
151. Martini A, Magrini U, Scelsi M, Capelli V, Barberis L. Chronic mesangioproliferative IgA glomerulonephritis complicated by a rapidly progressive course in a 14-year-old-boy. Nephron 29: 164-166, 1981.
152. McCoy RC, Abramowsky CR, Tisher CC. IgA nephropathy. Am J Pathol 76:123-148, 1974.
153. McLean RH, Wyatt RJ, Julian BA. Complement phenotypes in glomerulonephritis: Increased frequency of homozygous null C4 phenotypes in IgA nephropathy and Henoch-Schönlein purpura. Kidney Int 26: 855-860, 1984.
154. Michael J, Jones NF, Davies DR, Tighe JR. Recurrent haematuria: Role of renal biopsy and investigative morbidity. Br Med J 1: 686-688, 1976.
155. Mina SN, Murphy WM. IgA nephropathy. A comparative study of the clinicopathologic features in children and adults. Am J Clin Pathol 83: 669-675, 1985.
156. Miura M, Endoh M, Nomoto Y, Sakai H. Long-term effect of urokinase therapy in IgA nephropathy. Clin Nephrol 32: 209-216, 1989.
157. Montoliu J, Darnell A, Torras A, Ercilla G, Valles M, Revert L. Familial IgA nephropathy: Report of two cases and brief review of the literature. Arch Intern Med 140: 1374-1375, 1980.
158. Moorhead JF, Chan MK, El-Nahas M, Varghese Z. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet ii: 1309-1311, 1982
159. Morel-Maroger L, Leathern A, Richet G. Glomerular abnormalities in nonsystemic diseases: Relationship between findings by light microscopy and immunofluorescence in 433 renal biopsy specimens. Am J Med 53:170-184, 1972.
160. Morel-Maroger L, Mery JP, Robert CL, Richet G. Mesangial IgA deposits. Perspect Nephrol Hypertens 1 Pt 1: 301-304, 1973.
161. Mustonen J, Pasternack A, Helin H, Nikkila M. Clinicopathologic correlations in a series of 143 patients with IgA glomerulonephritis. Am J Nephrol 5: 150-157, 1985.
162. Mustonen J, Pasternack A, Helin H, Rilva A, Penttinen K, Wager O, Harmoinen A. Circulating immune complexes, the concentration of serum IgA and the distribution of HLA antigens in IgA nephropathy. Nephron 29:170-175, 1981.
163. Mustonen J, Pasternack A, Helin H. The course of disease in patients with nephrotic syndrome and IgA nephropathy. Semin Nephrol 7: 374-376, 1987.
164. Mustonen J, Pasternack A, Rantala I. The nephrotic syndrome in IgA glomerulonephritis: Response to corticosteroid therapy. Clin Nephrol 20:172-176, 1983.
165. Nagy J, Breach H, Trinn C, Burger T. Clinical features and course of IgA glomerulonephritis. Acta Med Acad Sci Hung 39: 201-10, 1982.
166. Nagy J, Hámori A, Ambrus M, Hernádi E. More on IgA glomerulonephritis and HLA antigens. N Engl J Med 300:92, 1979.
167. Nagy J, Trinn C, Deák G, Schmelzer M, Burger T. The role of the tubulointerstitial changes in the prognosis of IgA glomerulonephritis. Klin Wochenachr 62:1094-1096, 1984.
168. Nakamoto Y, Asano Y, Dohi K, Fujioka M, Iida H, Kida H, Kibe Y, Hattori N, Takeuchi J. Primary IgA glomerulonephritis and Schonlein-Henoch purpura nephritis: Clinicopathological and immunohistological characteristics. Q J Med 47: 495-516, 1978.
169. Nakamura T, Ebihara I, Nagaoka I, Takahashi T, Tomino Y, Koide H. Abnormal regulation of insulin-like growth factor gene expression in peripheral blood mononuclear cells from patients with IgA nephropathy. Am J Nephrol 12: 292-302, 1992.
170. Navas-Palacioe JJ, Gutierrez-Millet V, Usera-Sárraga G, Garzón-Martin A. IgA nephropathy: An ultrastructural study. Ultrastruct Pathol 2:151-161, 1981
171. Neelakantappa K, Gallo GR, Baldwin DS. Proteinuria in IgA nephropathy. Kidney Int 33: 716-721, 1988.
172. Ng WL, Chan CW, Yeung CK, Hua SP. The pathology of primary IgA glomerulonephritis-a renal biopsy study. Pathology 13: 137143, 1981.
173. Ng WL, Loke SL, Yeung CK, Kwan S, Chan KW, Chan MK. Clinical and histopathological predictors of progressive disease in IgA nephropathy. Pathology 18: 29-34, 1986.
174. Nicholls K, Walker RG, Dowling JP, Kincaid-Smith P. "Malignant" IgA nephropathy. Am J Kidney Dis 5: 42-46, 1985.
175. Nicholls KM, Fairley KF, Dowling JP, Kincaid-Smith P. The clinical course of mesangial IgA associated nephropathy in adults. Q J Med 53: 227-250, 1984.
176. Nöel LH, Descamps B, Jungers P, Bach JF, Busson M, Suet C, Hors J, Dausset J. HLA antigen in three types of glomerulonephritis. Clin Immunol Immunopathol 10:19-23, 1978.
177. Nöel LH, Droz D, Gascon M, Berger J. Primary IgA nephropathy: From the first described cases to the present. Semin Nephrol 7:351354, 1987.
178. Nomura Y, Ohya N, Shimada M. A histopathological study on the prognosis of childhood IgA nephropathy and glomerular basement membrane lesions. Pediatr Nephrol 3: 242-247, 1989.
179. Nussenzveig I, Saldanha LB, Marcondes M. Primary mesangial IgA nephropathy in Sao Paulo, Brazil. Nephron 52:198-199, 1989.
180. O'Connell PJ, Ibels LS, Thomas MA, Harris M, Eckstein RP. Familial IgA nephropathy: A study of renal disease in an Australian Aboriginal family. Aust NZ J Med 17: 27-33, 1987.
181. Okada H, Suzuki H, Konishi K, Sakaguchi H, Saruta T. Histological alterations in renal specimens as indicators of prognosis of IgA nephropathy. Clin Nephrol 37: 235-238, 1992.
182. Okada K, Funai M, Kawakami K, Kagami S, Yano I, Kuroda Y. IgA nephropathy in Japanese children and adults: A comparative study of clinicopathological features. Am J Nephrol 10:191-197, 1990.
183. Okamura M, Kanayama Y, Negoro N, Inoue T, Takeda T. Longterm effects of calcium antagonists and angiotensin-converting enzyme inhibitors in patients with chronic renal failure of IgA nephropathy. Contrib Nephrol 90:161-165, 1991.
184. O'Meara Y, Green A, Carmody M, Donohoe J, Campbell E, Browne O, Walshe J. Recurrent glomerulonephritis in renal transplants: Fourteen years' experience. Nephrol Dial Transplant 4: 730-734, 1989.
185. Orlowski T, Gorski A, Rancewicz Z, Morzycka-Michalik M, Smogorzewski M, Maldyk M, Lao M, Szczesny-Nowicka B. IgA nephropathy: A long-term progressive study. Miner Electrolyte Metab 16: 54-56, 1990.
186. Packham DK, North RA, Fairley KF, Whitworth JA, Kincaid-Smith P. IgA glomerulonephritis and pregnancy. Clin Nephrol 30: 15-21, 1988.
187. Packham D, Whitworth JA, Fairley KF, Kincaid-Smith P. Histological features of IgA glomerulonephritis as predictors of pregnancy outcome. Clin Nephrol 30: 22-26, 1988.
188. Parai SK, Ghose T. IgA nephropathy in adults: Immunohiatologic findings and clinical course. Can Med Assoc J 132:1381-1384, 1985.
189. Pardo V, Pardo T, Clerch A, Strauss J, Esquenazi V. HLA Bw35 antigen as a marker for segmental sclerosis and progressive disease in IgA mesangial glomerulonephritis (MCG-A). Kidney Int 19:134, 1981.
190. Payton CD, McLay A, Boulton Jones JM. Progressive IgA nephropathy: The role of hypertension. Nephrol Dial Transplant 3: 138-142, 1988.
191. Pettersson E, Honkanen E, Törnroth T. Recurrence of IgA nephropathy with nephrotic syndrome in renal allograft. Nephron 41: 114-117, 1986.
192. Porro A, Lomonte C, Coratelli P, Passaveti G, Ferri GM, Assennato G. Chronic glomerulonephritis and exposure to solvents: A casereferent study. Br J Ind Med 49: 738-742, 1992.
193. Power DA, Muirhead N, Simpson JG, Nicholls AJ, Horne CHW, Catto GRD, Edward N. IgA nephropathy is not a rare disease in the United Kingdom. Nephron 40:180-184, 1985.
194. Praga M, Gutierrez-Millet V, Navas JJ, Ruilope LM, Morales JM, Alcazar JM, Bello I, Rodicio JL. Acute worsening of renal function during episodes of macroscopic hematuria in IgA nephropathy. Kidney Int 28: 69-74, 1986.
195. Propper DJ, Power DA, Simpson JG, Edward M, Catto GRD. The incidence, mode of presentation and prognosis of IgA nephropathy in northeast Scotland. Semin Nephrol 7: 363-366, 1987.
196. Rambausek M, Seelig HP, Andrassy K, Waldherr R, Lenhard V, Ritz E. Clinical and serological features of mesangial IgA glomerulonephritis. Proc Eur Dial Transplant Assoc 19: 663-668, 1983.
197. Rauterberg EW, Lieberknecht H-M, Wingen A-M, Ritz E. Complement membrane attack (MAC) in idiopathic IgA-glomerulonephritis. Kidney Int 31: 820-829, 1987.
198. 51Cr-EDTA clearance. Kidney Int 40: 1050-1054, 1991.
199. Rekola S, Bergstrand A, Bucht H. Development of hypertension in IgA nephropathy as a marker of poor prognosis. Am J Nephrol 10: 290-295, 1990.
200. Rekola S, Bergstrand A, Bucht H. IgA nephropathy: A retrospective evaluation of prognostic indices in 176 patients. Scand J Urol Nephrol 23: 37-60, 1989.
201. Remuzzi A, Perticucci E, Ruggenenti P, Mesconi L, Limonta M, Remuzzi G. Angiotensin converting enzyme inhibition improves glomerular-size-selectivity in IgA nephropathy. Kidney Int 39:12671273, 1991.
202. Richman AV, Mahoney JJ, Fuller TJ. Higher prevalence of HLA-B12 in patients with IgA nephropathy. Ann Intern Med 90: 201, 1979.
203. Robles NR, Gomez Campdera FJ, Anaya F, Niembro De Rasche E, Galan A, Rengel MA, Valderrabano F. IgA nephropathy with rapidly progressive course after kidney transplantation. Nephron 58: 487-488, 1991.
204. Rodicio JL. Idiopathic IgA nephropathy. Kidney Int 25: 717-729, 1984.
205. Roodnat JI, van Stiphout WAHJ, Rosendaal FR, van Es LA, Vandenbroucke JP. What do we really know about the long-term prognosis of IgA-nephropathy? J Nephrol 3:145-151, 1991.
206. Sabatier JC, Genin C, Assenat H, Colon S, Ducret F, Nerthoux FC. Mesangial IgA glomerulonephritis in HLA-identical brothers. Clin Nephrol 11: 35-38, 1979.
207. Savi M, Neri TM, Silvestri MG, Allegri L, Migone L. HLA antigen and IgA mesangial glomerulonephritis. Clin Nephrol 12:45-46, 1979.
208. Schena FP. A retrospective analysis of the natural history of primary IgA nephropathy worldwide. Am J Med 89: 209-215, 1990.
209. Schena FP, Gesualdo L, Montinaro V. Immunopathological aspects of immunoglobulin A nephropathy and other mesangial proliferative glomerulonephritides. J Am Soc Nephrol 2: S167-S172, 1992.
210. Schena FP, Montenegro M, Scivittaro V. Meta-analysis of randomised controlled trials in patients with primary IgA nephropathy (Berger's disease). Nephrol Dial Transplant Suppl 1: 47-52, 1990.
211. Schena FP, Scivittaro V, Di Cillo M, Ranieri E. Is Berger's disease a hereditary nephritis? Contrib Nephrol 80:118-125, 1990.
212. Schmekel B, Svalander C, Bucht H, Westberg NG. Mesangial IgA glomerulonephritis in adults: Clinical and histopathological observations. Acta Med Scand 210:363-372, 1961.
213. Schwarz A, Krause P-H, Offermann G, Keller F. Recurrent and de novo renal disease after kidney transplantation with or without cyclosporine A. Am J Kidney Dis 17: 524-531, 1991.
214. Scolari F, Amoroso A, Savoldi S, Prati E, Scaini P, Manganoni A, Boreli I, Mazzola G, Canale L, Sacchi G, Miglietti N, Cristinelli L, Curtoni ES, Binds PL, Bonomelli D, Maiorca R. Familial occurrence of primary glomerulonephritis: Evidence for a role of genetic factors. Nephrol Dial Transplant 7: 587-596, 1991.
215. Shigematsu H, Kobayashi Y, Tateno S, Tsukada M. Ultrastructure of acute glomerular injury in IgA nephritis. Arch Pathol Lab Med 104: 303-307, 1980.
216. Shirai T, Tomino Y, Sato M, Yoehiki T, Itoh T. IgA nephropathy: Clinicopathology and immunopathology. Contrib Nephrol 9:88-100, 1978.
217. Simon P, Ramée MP, Ang KS, Genetet B, Fauchet R. Minimum prevalence and evaluation of IgA nephropathy in a French region with 250,000 inhabitants: Seven year follow-up. Kidney Int 24:137, 1983.
218. Sinniah R. IgA mesangial nephropathy: Berger's disease. Am J Nephrol 5: 7383, 1985.
219. Sinniah R, Javier AR, Ku G. The pathology of mesangial IgA nephritis with clinical correlation. Histopathology 5:469-490, 1981.
220. Sinniah R, Pwee HS, Lim CH. Glomerular lesions in asymptomatic microscopic hematuria discovered on routine medical examination. Clin Nephrol 5: 216-228, 1976.
221. Sissons JGP, Woodrow DF, Curtis JR, Evans DJ, Gower PE, Sloper JC, Peters DK. Isolated glomerulonephritis with mesangial IgA deposits. Br Med J 3:611-614, 1975.
222. Smith SM, Tung KS. Incidence of IgA-related nephritides in American Indians in New Mexico. Hum Pathol 16:181-184, 1985.
223. Southwest Pediatric Nephrology Study Group. A multicenter study of IgA nephropathy in children A report of the Southwest Pediatric Nephrology Study Group. Kidney Int 22: 643-652, 1982.
224. Suganuma T, Morozumi K, Satoh K, Yosida A, Fujinami T, Uchida K, Yamada N, Orihara A, Tanaka Y, Shinmura I, Kodera K, Takeda A, Taira N, Kano T, Takagi H. Studies of IgA nephropathy in renal transplantation. Transplant Proc 21: 2123-2127, 1989.
225. Suzuki S. Participation of complement components in glomerular deposition in IgA nephropathy. Jpn J Nephrol 31:1029-1037, 1989.
226. Suzuki S, Sato H, Kobayashi H, Takayama R, Maruyama Y, Ogino S, Ueno H, Inomata A, Nishi S, Saito T, In H, Arakawa M. Comparative study of IgA nephropathy with acute and insidious onset: Clinical, laboratory and pathological findings. Am J Nephrol 12: 22-28, 1992.
227. Suzuki J, Yoshikawa N, Nakamura H. A quantitative analysis of the mesangium in children with IgA nephropathy: Sequential study. J Pathol 161: 57-64, 1990.
228. Swanepoel CR, Madaus S, Cassidy MJD, Temple-Camp C, Van Diggelen NT, Pascoe MD, van Zyl-Smit R. IgA nephropathy-Groote Schuur Hospital experience. Nephron 53:61-64, 1989.
229. Syré G. IgA mesangial glomerulonephritis; significance and pathogenesis of segmental-focal glomerular lesions. Virchows Arch [A] 402:11-24, 1983.
230. Taguchi T, von Bassewitz DB, Takebayashi S, Harada T. A comparative study of IgA nephritis in Japan and Germany: An approach to its geopathology. Pathol Res Pract 182: 358-367, 1987.
231. Takebayashi S, Yanase K. Asymptomatic urinary abnormalities found via the Japanese school screening program: A clinical, morphological and prognostic analysis. Nephron 61:82-88, 1992.
232. Tateno S, Kobayashi Y. Quantitative analysis of mesangial areas in serial biopsied patients with IgA nephropathy. Nephron 46: 28-33, 1987.
233. Thomas M, Ibels LS, Abbot N. IgA nephropathy associated with mastitis and haematuria. Br Med J 291:867-868, 1985.
234. Tojo S, Hatano M, Honda N, Miyahara T, Sugino N, Narita M, Sakai H. Natural history of IgA nephropathy in Japan. Semin Nephrol 7: 386-388, 1987.
235. Tolkoff-Rubin NE, Cosimi AB, Fuller T, Rubin RH, Colvin RB. IgA nephropathy in HLA-identical siblings. Transplantation 26: 430-433, 1978.
236. Tomino Y, Funahiki K, Yaguchi Y, Shinto I, Koide H, Furuhata A, Murata Y, Shirai T. Computer imaging analysis of the correlation between intensities of glomerular immune-deposits and histopathology in patients with IgA nephropathy. Am J Med Sci 302: 278-283, 1991.
237. Ueda Y, Sakai O, Yamagata M, Kitajima T, Kawamun K. IgA glomerulonephritis in Japan. Contrib Nephrol 4: 36-47, 1977.
238. van de Putte LB, de la Riviere GB, van Breda Vrieeman PJC. Recurrent or persistent hematuria: Sign of mesangial immunecomplex deposition. N Engl J Med 290:1165-1170, 1974.
239. van der Peet J, Arisz L, Brentjens JRH, Marrink J, Hoedemaeker PH. The clinical course of IgA nephropathy in adults. Clin Nephrol 8: 335-340, 1977.
240. van Es LA. Pathogenesis of IgA nephropathy. Kidney Int 41:17201729, 1992.
241. Vangelista A, Frasca GM, Mondini S, Bonomini V. Idiopathic IgA niMimpil nephropathy; Immunohiatological features. Contrib Nephrol 40:167-173, 1984.
242. Velo M, Lozano L, Egido J, Gutierrez-Millet V, Hernando L. Natural history of IgA nephropathy in patients followed up for more than ten years in Spain. Semin Nephrol 7: 346-350, 1987.
243. Waldherr R, Rambausek M, Rauterherg W, Andrassy K, Ritz E. Immunohistochemical features of mesangial IgA glomerulonephritis. Contrib Nephrol 40: 99-106, 1984.
244. Waldo FB, Alexander R, Wyatt RJ, Kohaut EC. Alternate-day prednisone therapy in children with IgA-associated nephritis. Am J Kidney Dis 13: 55-60, 1989.
245. Walker RG, Yu SH, Owen JE, Kincaid-Smith P. The treatment of m-angial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: A two-year prospective trial. Clin Nephrol 34: 103-107, 1985.
246. Welch TR, Fryer C, Shely E, Witte DP, Quinlan M. Double-blind, controlled trial of short-term prednisone therapy in immunoglobulin A glomerulonephritis. J Pediatr 121: 474-477, 1992.
247. Widstam-Attorps U, Berg U, Bohman S-O, Lefvert A-K. Proteinuria and renal function in relation to renal morphology: A clinicopathological study of IgA nephropathy at the time of kidney biopsy. Clin Nephrol 38: 245-253, 1992.
248. Wilson C. Immunohistopatholggy of the kidney. In: Rose N, Friedman W, eds. Clinical immunology. Washington, DC: American Society for Microbiology, pp. 692-700, 1976.
249. Woo KT. IgA nephritis: A review of the pathogenetic mechanisms and the rationale for therapy. Ann Acad Med Singapore 18: 702-706; 1989
250. Woo KT, Chiang GSC, Edmondson RPS, Wu AYT, Lee EJC, Pwee HS, Lim CH. Glomerulonephritis in Singapore: An overview. Ann Acad Med Singapore 15: 20-31, 1986.
251. Woo KT, Chiang GSC, Lau YK, Lim CH. IgA nephritis in Singapore: Clinical, prognostic indices, and treatment. Semin Nephrol 7: 379381 1987.
252. Woo KT, Edmondson RP, Yap HK, Wu AY, Chiang GS, Lee EJ, Pwee HS, Lim CH. Effects of triple therapy on the progression of mesangial proliferative glomerulonephritis. Clin Nephrol 27: 56-64, 1987.
253. Woo KT, Edmondson RPS, Wu AYT, Chiang GS, Pwee HS, Lim CH. The natural history of IgA nephritis in Singapore. Clin Nephrol 25:15-21 1986.
254. Woo KT, Lee GSL, Lau YK, Chiang GSC, Lim CH. Effects of triple therapy in IgA nephritis: A follow-up study 5 years later. Clin Nephrol 36: 60-66, 1991.
255. Woo KT, Wong KS, Lau YK, Chiang GS, Lim CH. Hypertension in IgA nephropathy. Ann Acad Med Singapore 17: 583-588, 1988.
256. Woodroffe AJ, Bannister KM, Bellon MS, Hale GM, Clarkson AR. Do local hemodynamic alterations mediate injury in IgA nephropathy? Semin Nephrol 7: 341-343, 1987.
257. Woodroffe AJ, Thomson NM, Meadows R, Lawrence JR. IgA-associated glomerulonephritis. Aust NZ J Med 5:97-100, 1975.
258. Wyatt RJ. Can one predict the prognosis in patients with IgA nephropathy from the analysis of serum complement? Pediatr Nephrol 3: 467, 1989.
259. Wyatt RJ, Julian BA, Bhathena DB, Mitchell BL, Holland NH, Malluche HH. IgA nephropathy: Presentation, clinical course, and prognosis in children and adults. Am J Kidney Dis 4:192-200, 1984.
260. Wyatt RJ, Julian BA, Rivas ML. Role for specific complement phenotypes and deficiencies in the clinical expression of IgA nephropathy. Am J Med Sci 301:115-123, 1991.
261. Wyatt RJ, Julian BA, Woodford SY, McLean RH, Thompson JS. Immunogenetic markers as prognostic features in patients from Kentucky with IgA nephropathy. Semin Nephrol 7: 389-392, 1987.
262. Wyatt RJ, Rivas ML, Julian BA, Quiggins PA, Woodford SY, McMorrow RG, Baehler RW. Regionalization in hereditary IgA nephropathy. Am J Hum Genet 41:36-50, 1987.
263. Yokoska H, Nagase M, Maeda T, Koide K. Mesangial IgA glomerulonephritis: Clinicopathological study of 85 cases. Contrib Nephrol 9:101-110, 1978.
264. Yoshimura M, Kida H, Abe T, Takeda S, Katagiri M, Hatton N. Significance of IgA deposits on the glomerular capillary walls in IgA nephropathy. Am J Kidney Dis 9: 404-409, 1987.
265. Zidar N, Ferluga D, Volavsek M, Vizjak A, Luzar S, Kveder R. Renal extraglomerular vascular immune deposits in IgA glomerulonephritis. Kidney Int 42:1444-1449, 1992.
266. Zimmerman SW, Burkholder PM. Immunoglobulin A nephropathy. Arch Intern Med 135:1217-1223, 1975.